Pfizer announced Friday that it will be seeking authorization for a new antiviral pill to treat COVID-19 that clinical trials showed to be highly effective among those who are at high risk from the ...

Pfizer Paxlovid sits in a white blister pack on the clinic counter, two colors of tablets side by side, waiting for a patient who has just tested positive for COVID?19 and is still scrolling their ...

WASHINGTON — Pfizer said Tuesday that its experimental COVID-19 pill appears effective against the omicron variant. The company also said full results of its 2,250-person study confirmed the pill's ...

The Food and Drug Administration (FDA) has authorized Pfizer’s antiviral pill, Paxlovid, to treat COVID-19. The pill, the first to be authorized in the U.S., will be used to treat high-risk ...

Pfizer’s CEO said on Tuesday an antiviral drug to treat COVID-19 which began a Phase 1 study in March could be available by the end of this year. On CNBC’s "Squawk Box," Pfizer CEO Albert Bourla was ...

Pfizer's Covid-19 antiviral pills being manufactured in a laboratory in Freiburg, Germany. The Paxlovid pill has been shown to cut hospitalization or death by nearly 90 percent among newly-infected, ...

Pfizer announced Tuesday that it is seeking emergency use authorization from the US Food and Drug Administration for its experimental antiviral Covid-19 pill, known as PF-07321332 or Paxlovid. Pfizer ...

NEW YORK -- A course of pills developed by Pfizer can slash the risk of being hospitalized or dying from COVID-19 by 89% if taken within three days of developing symptoms, according to results ...

GENEVA (AP) - Nearly three dozen companies worldwide will soon start making generic versions of Pfizer's coronavirus pill, the U.N.-backed Medicines Patent Pool that negotiated the deal said Thursday.

Pfizer announced Wednesday it has begun phases 2 and 3 of its pediatric clinical trial for Paxlovid, its COVID-19 antiviral treatment. The study will look into how effective and safe the treatment is ...

The Omicron variant of the coronavirus is causing Covid-19 cases to spike, with an average of more than 747,000 new cases a day, according to the latest numbers from Johns Hopkins University. That's ...